Reference |
---|
Kim H, Kim K, Kim B, Cho M, Lee S. The effect of vascular endothelial growth factor on osteoclastogenesis in rheumatoid arthritis. PLoS ONE. 2015;10:e0124909 pubmed publisher
|
Holt V, Caplan A, Haynesworth S. Identification of a subpopulation of marrow MSC-derived medullary adipocytes that express osteoclast-regulating molecules: marrow adipocytes express osteoclast mediators. PLoS ONE. 2014;9:e108920 pubmed publisher
|
Park S, Park D, Bhattarai D, Lee K, Kim J, Bae Y, et al. 2-(trimethylammonium) ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate suppresses osteoclast maturation and bone resorption by targeting macrophage-colony stimulating factor signaling. Mol Cells. 2014;37:628-35 pubmed publisher
|
Kim J, Jin X, Sohn Y, Jin X, Jeon H, Kim E, et al. Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling. Cancer Lett. 2014;353:194-200 pubmed publisher
|
Moon S, Lim M, Park J, Byun J, Kim S, Park M, et al. Dual-specificity phosphatase 5 attenuates autoimmune arthritis in mice via reciprocal regulation of the Th17/Treg cell balance and inhibition of osteoclastogenesis. Arthritis Rheumatol. 2014;66:3083-95 pubmed publisher
|
Pathak J, Bravenboer N, Verschueren P, Lems W, Luyten F, Klein Nulend J, et al. Inflammatory factors in the circulation of patients with active rheumatoid arthritis stimulate osteoclastogenesis via endogenous cytokine production by osteoblasts. Osteoporos Int. 2014;25:2453-63 pubmed publisher
|
Hu H, Wang J, Gupta A, Shidfar A, Branstetter D, Lee O, et al. RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase. Breast Cancer Res Treat. 2014;146:515-23 pubmed publisher
|
Tseng F, Chia W, Shyu J, Gou G, Sytwu H, Hsia C, et al. Interactomics profiling of the negative regulatory function of carbon monoxide on RANKL-treated RAW 264.7 cells during osteoclastogenesis. BMC Syst Biol. 2014;8:57 pubmed publisher
|
Zinonos I, Luo K, Labrinidis A, Liapis V, Hay S, Panagopoulos V, et al. Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer. Int J Oncol. 2014;45:532-40 pubmed publisher
|
Zauli G, Celeghini C, Monasta L, Martinelli M, Luppi S, Gonelli A, et al. Soluble TRAIL is present at high concentrations in seminal plasma and promotes spermatozoa survival. Reproduction. 2014;148:191-8 pubmed publisher
|
Nistala H, Lee Arteaga S, Smaldone S, Siciliano G, Ramirez F. Extracellular microfibrils control osteoblast-supported osteoclastogenesis by restricting TGF{beta} stimulation of RANKL production. J Biol Chem. 2010;285:34126-33 pubmed publisher
|
Styrkarsdottir U, Halldorsson B, Gretarsdottir S, Gudbjartsson D, Walters G, Ingvarsson T, et al. New sequence variants associated with bone mineral density. Nat Genet. 2009;41:15-7 pubmed publisher
|
Min J, Kim Y, Kim Y, Kim E, Gho Y, Kang I, et al. Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand. J Biol Chem. 2003;278:39548-57 pubmed
|
Josien R, Wong B, Li H, Steinman R, Choi Y. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol. 1999;162:2562-8 pubmed
|